Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Yun Zhou

Yun Zhou

Johns Hopkins University School of Medicine USA

Elizabeth A Boerger

Elizabeth A Boerger

Slippery Rock University USA

Theodore A Petti

Theodore A Petti

Rutgers-Robert Wood Johnson Medical School USA

Ahmed Ammar

Ahmed Ammar

Dammam University Saudi Arabia

Alan M. Palmer

Alan M. Palmer

Cerebroscience Ltd UK

Alberto E. Musto

Alberto E. Musto

Eastern Virginia Medical School USA

Alessandro Morelli

Alessandro Morelli

Genova University Italy

Alex Bekker

Alex Bekker

Rutgers New Jersey Medical School USA

Dementia 2019

Sessions/Tracks

Track 1: Managing Dementia

Dementia is that the term accustomed describe the symptoms of many conditions that touching the brain. The normally seen condition is Alzheimer’s, and alternative includes brain disease. Symptoms seen at early stages square measure temperament changes, withdrawal, state of mind, confusion and apathy. Early diagnosing helps with providing early treatment, support and designing. Medications would possibly facilitate with some symptoms of insanity, however no permanent cure.

Majority of individuals with insanity square measure higher than age sixty-five, the condition isn't traditional for all older people. The prevalence of insanity gets high with age, however it’s not if an older person can develop it. whereas solely 1-in-4 people with Alzheimer’s sickness or insanity has been diagnosed. Few additional things we'd like to grasp regarding tube insanity, insanity with lewy bodies, Fronto-temporal insanity, Rarer causes of insanity, brain disorder, HIV-related psychological feature impairment, delicate psychological feature impairment.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2019 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2019 USA | Dementia Conferences 2019 Europe | Dementia Conferences 2019 Asia | Brain Disorder Conferences


5th International Conference on Neuro-Oncology and Brain Tumor, February 27-28, 2019 Seoul, South Korea; 8th International Conference on Brain Injury and Neuroscience, March 14-15, 2019 Paris, France; CPD Accredited Annual Congress on Neurology & Neuroscience, March 14-15, 2019 Paris, France; 5th International Conference on Spine and Spinal Disorders, April 25-26, 2019 Rome, Italy; 9th International Conference on Addictive Disorders and Alcoholism, June 17-18, 2019 Brisbane, Australia; 32nd European Neurology Congress, July 22-24, 2019 London, UK; American Neuroscience and Neurosurgery Congress, June 21-22, 2019 Ottawa, Canada; World Congress on Advances in Brain Injury, October 21-22, 2019 Tokyo, Japan; 26th International Conference on Neurology: Neurochemistry, Neuropharmacology and Neurosciences, October 28-29, 2019 Abu Dhabi, UAE

Related Association:

USA and Canada:

American Brain Tumor Association; American Cancer Society; American Parkinson Disease Association; American RSD Hope Organization and American Sleep Apnea Association; American Speech-Language-Hearing Association; Autism Network International; Autism Science Foundation and Autism Society of America; Autism Society of America Foundation

European Union and UK:

Alzheimer's & Dementia Help Germany; Alzheimer Europe; German Alzheimer Society; Federazione Alzheimer Italia; Alzheimer's & Dementia Help; Giovanni B Frisoni; Actifcare; Association France Alzheimer

Asia-Pacific and Middle East:

Alzheimer's & Dementia Help; Dementia Caregiver Resources across India; Dementia Bangalore; Alzheimer's Disease – Aarogya; Japan - Dementia Friendly Communities; Alzheimer's Association Japan; Dementia care in Japan; China Alzheimer's Project; Alzheimer associations China

Persons with dementia have multiple psychological feature deficits that embody every memory impairment, that affects the flexibleness to seek out new data or recall data antecedently learned, and one or extra of the next symptoms-aphasia, apraxia, agnosia, or government dysfunction-such that the psychological feature deficits negatively have an impression on social or activity functioning with a giant decline in previous skills. to boot, persons with dementia generally suffer from comorbid conditions that extra complicate care and impede best outcomes. Therefore, developing caregiving ways individuals with dementia is pressing, given this increasing prevalence and so the associated burden that dementia places not solely on the people, but on the caregivers, relations, and so the resources of the health care system. standard views relating geriatric nursing generally paint a picture of the care as being slow paced sure and fewer hard than acute care. However, care of the aged, and significantly those with dementia, is sometimes difficult, unpredictable, and unstable.

This session includes education and coaching of medical professionals, care and quality of life, Person focused care, psychological feature coaching, Support and coaching for casual and skilled careers, putt knowledge domain into apply, Non-pharmacological Interventions, practical foods, Art, music and life vogue.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2019 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2019 USA | Dementia Conferences 2019 Europe | Dementia Conferences 2019 Asia | Brain Disorder Conferences

5th International Conference on Neuro-Oncology and Brain Tumor, February 27-28, 2019 Seoul, South Korea; 8th International Conference on Brain Injury and Neuroscience, March 14-15, 2019 Paris, France; CPD Accredited Annual Congress on Neurology & Neuroscience, March 14-15, 2019 Paris, France; 5th International Conference on Spine and Spinal Disorders, April 25-26, 2019 Rome, Italy; 9th International Conference on Addictive Disorders and Alcoholism, June 17-18, 2019 Brisbane, Australia; 32nd European Neurology Congress, July 22-24, 2019 London, UK; American Neuroscience and Neurosurgery Congress, June 21-22, 2019 Ottawa, Canada; World Congress on Advances in Brain Injury, October 21-22, 2019 Tokyo, Japan; 26th International Conference on Neurology: Neurochemistry, Neuropharmacology and Neurosciences, October 28-29, 2019 Abu Dhabi, UAE

Related Association:

USA and Canada:

American Stroke Association; Brain Injury Association of America; Brain Injury Resource Center; Cerebral Palsy Foundation and CHADD; Childhood Brain Tumor Foundation; Children's Hemiplegia and Stroke Association; Christopher and Dana Reeve Foundation; Lewy Body Dementia Association

European Union and UK:

France - Dementia Friendly Communities; Alzheimer Society of Spain; Alzheimer Care in Spain; Synapsis Foundation; Switzerland - National Dementia Strategies; Czech Alzheimer Society; Alzheimer Austria

Asia-Pacific and Middle East:

Alzheimer Society of Manitoba; Memory Makers for Alzheimer's; EMDA; Thailand Honorary Consulate; Saudi Alzheimer’s disease Association; Dementia Friends HK; Alzheimer's Disease Association of the Philippines; Dementia Society of the Philippines; Federation Member Associations

Track 3: Alzheimer’s Disease Imaging

Scientists inspect the brain’s gray substance once work regarding Alzheimer’s disease. A contemporary study found that degenerating nervous tissue within the brain can be Associate in Nursing early indicator of malady. A study was printed in Radiology that concludes that nervous tissue plays a vital role in however the disease strikes and progresses. Abnormal deposits of proteins that type amyloid plaques and letter tangles everywhere the brain in Alzheimer’s disease. It can even be characterized by shrinkage of brain tissues thanks to neurons loss.

This session includes Amyloid and letter imaging, Imaging animal models, Imaging and biological science, New strategies in imaging, Structural and purposeful MRI, antielectron emission imaging, spectrometry, EEG and brain mapping, SPECT imaging, Imaging correlates of clinical, psychological feature and biomarker variables.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2019 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2019 USA | Dementia Conferences 2019 Europe | Dementia Conferences 2019 Asia | Brain Disorder Conferences

5th International Conference on Neuro-Oncology and Brain Tumor, February 27-28, 2019 Seoul, South Korea; 8th International Conference on Brain Injury and Neuroscience, March 14-15, 2019 Paris, France; CPD Accredited Annual Congress on Neurology & Neuroscience, March 14-15, 2019 Paris, France; 5th International Conference on Spine and Spinal Disorders, April 25-26, 2019 Rome, Italy; 9th International Conference on Addictive Disorders and Alcoholism, June 17-18, 2019 Brisbane, Australia; 32nd European Neurology Congress, July 22-24, 2019 London, UK; American Neuroscience and Neurosurgery Congress, June 21-22, 2019 Ottawa, Canada; World Congress on Advances in Brain Injury, October 21-22, 2019 Tokyo, Japan; 26th International Conference on Neurology: Neurochemistry, Neuropharmacology and Neurosciences, October 28-29, 2019 Abu Dhabi, UAE

Related Association:

USA and Canada:

Lewy Body Dementia Association; Jain Foundation and John Douglas French Alzheimer's Foundation; Intractable Childhood Epilepsy Alliance; Huntington's Disease Society of America; Michael J. Fox Foundation for Parkinson's Research; Children's Hemiplegia and Stroke Association; Christopher and Dana Reeve Foundation

European Union and UK:

Federazione Alzheimer Italia; Alzheimer's & Dementia Help; Giovanni B Frisoni; Association France Alzheimer; France - Dementia Friendly Communities; Alzheimer Society of Spain; Alzheimer Care in Spain

Asia-Pacific and Middle East:

Alzheimer And Related Dementia Society Nepal; Mental Illness Dementia and Family in China; Alzheimer Society of B.C.; Grey zone - Coping with senility in Japan; ARDSI Kolkata; Alzheimer's & Dementia Help; Dementia Caregiver Resources across India; Dementia Bangalore; Alzheimer's Disease – Aarogya

Track 4: Causes and Prevention of Alzheimer’s

Alzheimer's is caused by neuron death. it's a disorder within which the death of brain cells causes blackout and psychological feature decline. the full size of the brain shrinks in Alzheimer's disease, nerve cells and connections within the tissue increasingly reduced, that can't be seen or tested within the living brain laid low with Alzheimers, post-mortem/autopsy can forever show small inclusions within the nerve tissues, referred to as plaques and tangles. Plaques area unit found between the dying cells within the brain - from the build-up of a macromolecule referred to as beta-amyloid (amyloid plaques). The tangles exist within the brain neurons, from a disintegration of second macromolecule, called tau.

Worldwide, with dementedness or connected disorders nearly forty four million individuals have suffered in 2015, past results shown thirty five.66 million population lived with dementedness  worldwide in year 2010, with numbers expected to just about double every twenty years, to 65.7 million in 2030 and one hundred fifteen.4 million in 2050. In 2010, 58 per cent of all population with dementedness lived in countries with lower or moderate incomes, with this proportion anticipated to rise to sixty-three until 2030 and seventy-one by 2050. This condition is anticipated to double by 2030 and quite triple by 2050 to one hundred fifteen million.

In this track we will discuss on neurologic changes in brain, Amyloid macromolecule, Genetic associations and condition genes, Role of Apo compound protein E, Brain trauma, Metabolic syndrome and Alzheimer’s unwellness, macromolecule misfolding, aggregation and toxicity, Disease-causing mutations, medical specialty and prevalence, simple protein modification, deoxyribonucleic acid methylation, Alzheimer’s unwellness interference.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2019 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2019 USA | Dementia Conferences 2019 Europe | Dementia Conferences 2019 Asia | Brain Disorder Conferences

5th International Conference on Neuro-Oncology and Brain Tumor, February 27-28, 2019 Seoul, South Korea; 8th International Conference on Brain Injury and Neuroscience, March 14-15, 2019 Paris, France; CPD Accredited Annual Congress on Neurology & Neuroscience, March 14-15, 2019 Paris, France; 5th International Conference on Spine and Spinal Disorders, April 25-26, 2019 Rome, Italy; 9th International Conference on Addictive Disorders and Alcoholism, June 17-18, 2019 Brisbane, Australia; 32nd European Neurology Congress, July 22-24, 2019 London, UK; American Neuroscience and Neurosurgery Congress, June 21-22, 2019 Ottawa, Canada; World Congress on Advances in Brain Injury, October 21-22, 2019 Tokyo, Japan; 26th International Conference on Neurology: Neurochemistry, Neuropharmacology and Neurosciences, October 28-29, 2019 Abu Dhabi, UAE

Related Association:

USA and Canada:

Alternating Hemiplegia of Childhood Foundation; Alzheimer's Drug Discovery Foundation; Alzheimer's Association and Alzheimer's Foundation of America; American Association of Health and Disability; American Autoimmune Related Diseases Association; American Behcet's Disease Association and American Brain Coalition; American Brain Tumor Association; American Cancer Society; American Headache Society Committee for Headache Education; American Heart Association

European Union and UK:

Lowe Syndrome Association; The Alzheimer Society of Ireland; Alzheimer Society London; Alzheimer Society Middlesex; Alzheimer's & Dementia Help Germany; Alzheimer Europe; German Alzheimer Society; Federazione Alzheimer Italia

Asia-Pacific and Middle East:

Dementia Friends HK; Alzheimer's Disease Association of the Philippines; Dementia Society of the Philippines Dementia Caregiver Resources across India; Dementia Bangalore; Alzheimer's Disease – Aarogya; Japan - Dementia Friendly Communities; Grey zone - Coping with senility in Japan

Track 5: Alzheimer’s Disease Diagnosis and Symptoms

Alzheimer's is caused by nerve cell death. it's a nervous disorder during which the death of brain cells causes cognitive state and psychological feature decline. the whole size of the brain shrinks in Alzheimer's disease, nerve cells and connections within the tissue more and more reduced, that can't be seen or tested within the living brain tormented by Alzheimer's disease, post-mortem/autopsy can perpetually show small inclusions within the nerve tissues, referred to as plaques and tangles. Plaques area unit found between the dying cells within the brain - from the build-up of a super molecule referred to as beta-amyloid. The tangles exist within the brain neurons, from a disintegration of second super molecule, called tau.

Worldwide, with dementia or connected disorders nearly forty-four million individuals have suffered in 2015, past results shown 35 million population lived with dementia worldwide in year 2010, with numbers expected to just about double every twenty years, to 65.7 million in 2030 and one hundred fifteen million in 2050. In 2010, 58 per cent of all population with dementia lived in countries with lower or moderate incomes, with this proportion anticipated to rise to sixty-three until 2030 and seventy-one by 2050. This condition is anticipated to double by 2030 and quite triple by 2050 to one hundred fifteen million.

In this track we are able to discuss on medical specialty changes in brain, Amyloid super molecule, Genetic associations and susceptibleness genes, Role of Apo conjugated protein E, Brain trauma, Metabolic syndrome and Alzheimer’s disease, super molecule misfolding, aggregation and toxicity, Disease-causing mutations, medical specialty and prevalence, simple protein modification, deoxyribonucleic acid methylation, Alzheimer’s disease prevention.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2019 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2019 USA | Dementia Conferences 2019 Europe | Dementia Conferences 2019 Asia | Brain Disorder Conferences

5th International Conference on Neuro-Oncology and Brain Tumor, February 27-28, 2019 Seoul, South Korea; 8th International Conference on Brain Injury and Neuroscience, March 14-15, 2019 Paris, France; CPD Accredited Annual Congress on Neurology & Neuroscience, March 14-15, 2019 Paris, France; 5th International Conference on Spine and Spinal Disorders, April 25-26, 2019 Rome, Italy; 9th International Conference on Addictive Disorders and Alcoholism, June 17-18, 2019 Brisbane, Australia; 32nd European Neurology Congress, July 22-24, 2019 London, UK; American Neuroscience and Neurosurgery Congress, June 21-22, 2019 Ottawa, Canada; World Congress on Advances in Brain Injury, October 21-22, 2019 Tokyo, Japan; 26th International Conference on Neurology: Neurochemistry, Neuropharmacology and Neurosciences, October 28-29, 2019 Abu Dhabi, UAE

Related Association:

USA and Canada:

Acoustic Neuroma Association; Aicardi Syndrome Foundation; Alternating Hemiplegia of Childhood Foundation; Alzheimer's Drug Discovery Foundation; Alzheimer's Association and Alzheimer's; Foundation of America; American Association of Health and Disability; American Autoimmune Related Diseases Association; American Behcet's Disease Association and American Brain Coalition

European Union and UK:

ALS Association and ALS Therapy Development Institute; Attention Deficit Disorder; Association and Autism National Committee; Carter Center for Brain Research in Holoprosencephaly; Lowe Syndrome Association; The Alzheimer Society of Ireland; Alzheimer Society London; Alzheimer Society Middlesex

Asia-Pacific and Middle East:

International Radio Surgery Association; Asian Society Against Dementia; Alzheimer And Related Dementia Society Nepal; Mental Illness; Dementia and Family in China; Alzheimer Society of B.C.; Grey zone - Coping with senility in Japan; ARDSI Kolkata

Track 6: Alzheimer’s Disease Pathophysiology and Disease Mechanisms

Alzheimer’s illness may be a progressive dementia with loss of neurons and therefore the presence of 2 main microscopic neuropathological hallmarks: living thing amyloid plaques and living thing neurofibrillary tangles. Early onset AD, a rare familial kind, is caused because of mutation of 1 out of 3 genes: (amyloid precursor protein), (presenilin 2) or (presenilin 1). noncontinuous kind happens typically when age of sixty-five and accounts for many cases; it possibly results from a mix of genetic and influence of setting. Confirmed risk factors for noncontinuous AD square measure age and therefore the presence of the E4 gene of (Apo compound protein E). Amyloid plaques comprise in the main of the toxin amide amyloid (Aβ, Abeta), cleaved consecutive from a bigger precursor super molecule (APP) by 2 enzymes: β-secretase (also known as BACE1) and γ-secretase (comprising four proteins, presenilin is one among them). If APP is 1st cleaved by the catalyst α-secretase instead of β-secretase then Aβ isn't fashioned. Neurofibrillary tangles comprise in the main of the super molecule letter that binds with microtubules, that facilitating the neural transport system. letter uncoupling from tubules and aggregation into tangles inhibits transport and leads to activity of microtubule. Phosphorylation of letter may need a crucial role during this. Selective vulnerability of neural systems like the cholinergic, serotonergic, and noradrenergic and glutamatergic systems kind the idea of current rational medicine treatment.

This session includes Aging, Prions and Alzheimer’s illness, Cellular sign and cell to cell transmission, xerophilous harm and mitochondrial pathology, pathology in Alzheimer’s, barrier and transport, ontogenesis and stem cells and death.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2019 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2019 USA | Dementia Conferences 2019 Europe | Dementia Conferences 2019 Asia | Brain Disorder Conferences

5th International Conference on Neuro-Oncology and Brain Tumor, February 27-28, 2019 Seoul, South Korea; 8th International Conference on Brain Injury and Neuroscience, March 14-15, 2019 Paris, France; CPD Accredited Annual Congress on Neurology & Neuroscience, March 14-15, 2019 Paris, France; 5th International Conference on Spine and Spinal Disorders, April 25-26, 2019 Rome, Italy; 9th International Conference on Addictive Disorders and Alcoholism, June 17-18, 2019 Brisbane, Australia; 32nd European Neurology Congress, July 22-24, 2019 London, UK; American Neuroscience and Neurosurgery Congress, June 21-22, 2019 Ottawa, Canada; World Congress on Advances in Brain Injury, October 21-22, 2019 Tokyo, Japan; 26th International Conference on Neurology: Neurochemistry, Neuropharmacology and Neurosciences, October 28-29, 2019 Abu Dhabi, UAE

Related Association:

USA and Canada:

American Stroke Association; Brain Injury Association of America; Brain Injury Resource Center; Cerebral Palsy Foundation and CHADD; Childhood Brain Tumor Foundation; Children's Hemiplegia and Stroke Association; Christopher and Dana Reeve Foundation; Lewy Body Dementia Association

European Union and UK:

France - Dementia Friendly Communities; Alzheimer Society of Spain; Alzheimer Care in Spain; Synapsis Foundation; Switzerland - National Dementia Strategies; Czech Alzheimer Society; Alzheimer Austria

Asia-Pacific and Middle East:

Alzheimer Society of Manitoba; Memory Makers for Alzheimer's; EMDA; Thailand Honorary Consulate; Saudi Alzheimer’s disease Association; Dementia Friends HK; Alzheimer's Disease Association of the Philippines; Dementia Society of the Philippines; Federation Member Associations

Track 7: Neurodegenerative Diseases

Neurodegenerative diseases incorporate wide selection of disorders, characterized by the progressive degeneration or death of nerve cells. It affects animal tissue and causes completely different psychological science manifestations furthermore. it's Associate in Nursing umbrella term for a variety of conditions that notably influence the neurons within the human brain.

Genetic and environmental factors are shown to play an important role within the development of neurodegenerative diseases. Age is one in every of the key risk factors that's common between every type of neurodegenerative unwellness because it progresses at older ages ordinarily.

  • Cognition
  • Multiple Sclerosis
  • Parkinson's disease
  • Huntington's disease
  • Neurovascular Dysfunction and Neurodegeneration

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2019 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2019 USA | Dementia Conferences 2019 Europe | Dementia Conferences 2019 Asia | Brain Disorder Conferences

5th International Conference on Neuro-Oncology and Brain Tumor, February 27-28, 2019 Seoul, South Korea; 8th International Conference on Brain Injury and Neuroscience, March 14-15, 2019 Paris, France; CPD Accredited Annual Congress on Neurology & Neuroscience, March 14-15, 2019 Paris, France; 5th International Conference on Spine and Spinal Disorders, April 25-26, 2019 Rome, Italy; 9th International Conference on Addictive Disorders and Alcoholism, June 17-18, 2019 Brisbane, Australia; 32nd European Neurology Congress, July 22-24, 2019 London, UK; American Neuroscience and Neurosurgery Congress, June 21-22, 2019 Ottawa, Canada; World Congress on Advances in Brain Injury, October 21-22, 2019 Tokyo, Japan; 26th International Conference on Neurology: Neurochemistry, Neuropharmacology and Neurosciences, October 28-29, 2019 Abu Dhabi, UAE

Related Association:

USA and Canada:

Lewy Body Dementia Association; Jain Foundation and John Douglas French Alzheimer's Foundation; Intractable Childhood Epilepsy Alliance; Huntington's Disease Society of America; Michael J. Fox Foundation for Parkinson's Research; Children's Hemiplegia and Stroke Association; Christopher and Dana Reeve Foundation

European Union and UK:

Federazione Alzheimer Italia; Alzheimer's & Dementia Help; Giovanni B Frisoni; Association France Alzheimer; France - Dementia Friendly Communities; Alzheimer Society of Spain; Alzheimer Care in Spain

Asia-Pacific and Middle East:

Alzheimer And Related Dementia Society Nepal; Mental Illness Dementia and Family in China; Alzheimer Society of B.C.; Grey zone - Coping with senility in Japan; ARDSI Kolkata; Alzheimer's & Dementia Help; Dementia Caregiver Resources across India; Dementia Bangalore; Alzheimer's Disease – Aarogya

Track 8: Vascular Dementia

Vascular Dementia, otherwise known as multi-infarct dementia is that the second most elementary reason for insanity in additional seasoned people. Since it's a lower profile than Alzheimer's disease, several people do not speculate tube-shaped structure insanity once neglect finally ends up perceptibly venturous. It's to boot exhausting to research therefore it's exhausting to grasp exactly what variety of people expertise the sick effects of tube-shaped structure insanity. Current evaluations credit 15 August 1945 to twenty of insanity cases in additional established grown-ups to tube-shaped structure dementia. tube-shaped structure dementia happens once vessels that offer blood to the neural structure finally end up perceptibly blocked or restricted. Strokes happen once the provision of blood transference O to the mind is suddenly interrupt. Be that because it might, not all people with stroke can produce tube-shaped structure insanity. tube-shaped structure insanity will happen when your time as "noiseless" strokes collect. Frequently, tube-shaped structure dementia attracts regard for itself simply once the impact of such several strokes suggests that noteworthy handicap. Staying faraway from and dominant danger factors, for instance, diabetes, high blood pressure, smoking, and elevated steroid alcohol will facilitate check the danger of tube-shaped structure dementia.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2019 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2019 USA | Dementia Conferences 2019 Europe | Dementia Conferences 2019 Asia | Brain Disorder Conferences

5th International Conference on Neuro-Oncology and Brain Tumor, February 27-28, 2019 Seoul, South Korea; 8th International Conference on Brain Injury and Neuroscience, March 14-15, 2019 Paris, France; CPD Accredited Annual Congress on Neurology & Neuroscience, March 14-15, 2019 Paris, France; 5th International Conference on Spine and Spinal Disorders, April 25-26, 2019 Rome, Italy; 9th International Conference on Addictive Disorders and Alcoholism, June 17-18, 2019 Brisbane, Australia; 32nd European Neurology Congress, July 22-24, 2019 London, UK; American Neuroscience and Neurosurgery Congress, June 21-22, 2019 Ottawa, Canada; World Congress on Advances in Brain Injury, October 21-22, 2019 Tokyo, Japan; 26th International Conference on Neurology: Neurochemistry, Neuropharmacology and Neurosciences, October 28-29, 2019 Abu Dhabi, UAE

Related Association:

USA and Canada:

American Stroke Association; Brain Injury Association of America; Brain Injury Resource Center; Cerebral Palsy Foundation and CHADD; Childhood Brain Tumor Foundation; Children's Hemiplegia and Stroke Association; Christopher and Dana Reeve Foundation; Lewy Body Dementia Association

European Union and UK:

France - Dementia Friendly Communities; Alzheimer Society of Spain; Alzheimer Care in Spain; Synapsis Foundation; Switzerland - National Dementia Strategies; Czech Alzheimer Society; Alzheimer Austria

Asia-Pacific and Middle East:

Alzheimer Society of Manitoba; Memory Makers for Alzheimer's; EMDA; Thailand Honorary Consulate; Saudi Alzheimer’s disease Association; Dementia Friends HK; Alzheimer's Disease Association of the Philippines; Dementia Society of the Philippines; Federation Member Associations

Track 9: Alzheimer’s Clinical Trials and Studies

Clinical trials square measure inquired regarding examinations junction rectifier in people to decide if medicines square measure protected and viable. while not clinical analysis and the help of human volunteers, there is no higher medications, no compensatory action and no cure for Alzheimer's ill.

Clinical trials square measure often alluded to as clinical examinations; the terms square measure of utilized reciprocally, however their square measure retiring contrasts between them. Clinical trials look at new intercessions or medications to avoid, acknowledge or treat infection. A clinical report is any variety of clinical analysis together with people, paying very little heed as to if it's Associate in Nursing an intercession. Clinical examinations will likewise take a goose at totally different components of care, for instance, enhancing personal satisfaction.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2019 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2019 USA | Dementia Conferences 2019 Europe | Dementia Conferences 2019 Asia | Brain Disorder Conferences

5th International Conference on Neuro-Oncology and Brain Tumor, February 27-28, 2019 Seoul, South Korea; 8th International Conference on Brain Injury and Neuroscience, March 14-15, 2019 Paris, France; CPD Accredited Annual Congress on Neurology & Neuroscience, March 14-15, 2019 Paris, France; 5th International Conference on Spine and Spinal Disorders, April 25-26, 2019 Rome, Italy; 9th International Conference on Addictive Disorders and Alcoholism, June 17-18, 2019 Brisbane, Australia; 32nd European Neurology Congress, July 22-24, 2019 London, UK; American Neuroscience and Neurosurgery Congress, June 21-22, 2019 Ottawa, Canada; World Congress on Advances in Brain Injury, October 21-22, 2019 Tokyo, Japan; 26th International Conference on Neurology: Neurochemistry, Neuropharmacology and Neurosciences, October 28-29, 2019 Abu Dhabi, UAE

Related Association:

USA and Canada:

Acoustic Neuroma Association; Aicardi Syndrome Foundation; Alternating Hemiplegia of Childhood Foundation; Alzheimer's Drug Discovery Foundation; Alzheimer's Association and Alzheimer's; Foundation of America; American Association of Health and Disability; American Autoimmune Related Diseases Association; American Behcet's Disease Association and American Brain Coalition

European Union and UK:

ALS Association and ALS Therapy Development Institute; Attention Deficit Disorder; Association and Autism National Committee; Carter Center for Brain Research in Holoprosencephaly; Lowe Syndrome Association; The Alzheimer Society of Ireland; Alzheimer Society London; Alzheimer Society Middlesex

Asia-Pacific and Middle East:

International Radio Surgery Association; Asian Society Against Dementia; Alzheimer And Related Dementia Society Nepal; Mental Illness; Dementia and Family in China; Alzheimer Society of B.C.; Grey zone - Coping with senility in Japan; ARDSI Kolkata

Track 10: Therapeutic Targets and Mechanisms for Treatment

Alzheimer's illness could be a progressive neurodegenerative disease that's characterized histopathologically by the presence of plaques, principally composed of Abeta amyloid and the tangles, principally composed of hyper phosphorylated alphabetic character. To date, there's no treatment which will reverse the illness, and everyone this medical specialty is directed to address the symptoms of the illness. Here we tend to describe the efforts dedicated to attack the plaques and, in additional detail, the method of neurofibrillary degeneration, connected to the presence of the hyper phosphorylated tubule associated super molecule alphabetic character. we've known the various purported targets for medical specialty and the current data on them.

Treatment for Alzheimer's is coming into a brand new and exciting section, with many new medications starting clinical trials. several of those new therapies area unit supported our greatest current understanding of the pathologic process of Alzheimer's, and area unit designed to undertake to either slow or halt the progression of the illness. There are a unit many completely different theories underlying this effort, and these area unit in short reviewed. Therapies directed against some side of beta-amyloid formation, against neurofibrillary tangle formation and against the inflammatory response area unit all thought-about, as area unit the issues related to every space. it's nevertheless unclear that, if any of those approaches are undefeated, however the high level of activity in every of those 3 fields provides some hope that a good treatment for Alzheimer's is on the horizon.

This session includes Abeta, truncated and pGlu-Abeta, therapy, Neurotransmitter-based targets, medication targets, applied science, Anti-oxidants, Neurotrophic factors, super molecule aggregation, Deep brain stimulation, Misfolding and chaperones, cistron medical care, Drug-delivery systems.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2019 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2019 USA | Dementia Conferences 2019 Europe | Dementia Conferences 2019 Asia | Brain Disorder Conferences

5th International Conference on Neuro-Oncology and Brain Tumor, February 27-28, 2019 Seoul, South Korea; 8th International Conference on Brain Injury and Neuroscience, March 14-15, 2019 Paris, France; CPD Accredited Annual Congress on Neurology & Neuroscience, March 14-15, 2019 Paris, France; 5th International Conference on Spine and Spinal Disorders, April 25-26, 2019 Rome, Italy; 9th International Conference on Addictive Disorders and Alcoholism, June 17-18, 2019 Brisbane, Australia; 32nd European Neurology Congress, July 22-24, 2019 London, UK; American Neuroscience and Neurosurgery Congress, June 21-22, 2019 Ottawa, Canada; World Congress on Advances in Brain Injury, October 21-22, 2019 Tokyo, Japan; 26th International Conference on Neurology: Neurochemistry, Neuropharmacology and Neurosciences, October 28-29, 2019 Abu Dhabi, UAE

Related Association:

USA and Canada:

Acoustic Neuroma Association; Aicardi Syndrome Foundation; Alternating Hemiplegia of Childhood Foundation; Alzheimer's Drug Discovery Foundation; Alzheimer's Association and Alzheimer's; Foundation of America; American Association of Health and Disability; American Autoimmune Related Diseases Association; American Behcet's Disease Association and American Brain Coalition

European Union and UK:

ALS Association and ALS Therapy Development Institute; Attention Deficit Disorder; Association and Autism National Committee; Carter Center for Brain Research in Holoprosencephaly; Lowe Syndrome Association; The Alzheimer Society of Ireland; Alzheimer Society London; Alzheimer Society Middlesex

Asia-Pacific and Middle East:

International Radio Surgery Association; Asian Society Against Dementia; Alzheimer And Related Dementia Society Nepal; Mental Illness; Dementia and Family in China; Alzheimer Society of B.C.; Grey zone - Coping with senility in Japan; ARDSI Kolkata

Track 11: Animal Models and Translational Medicine

Animal models for Alzheimer’s illness it's vital to trust the human makeup and what's being sculptural in terms of the animal makeup. The moderator, Bradley Hyman, academic of neurology at Harvard grad school, that animal models of Alzheimer’s illness, supported the genetic science of the illness and the closely connected frontotemporal dementedness, replicate a minimum of a number of the pathology. Researchers are eminent at modeling terribly specific aspects of Alzheimer’s illness within the mouse (e.g., plaques, tangles). though these area unit incomplete models of the human illness, they need been well received within the field as doubtless relevant models to be used in drug discovery.

Patients with Alzheimer’s illness can show each amyloidopathy and tauopathy; but scientists usually focus, in a very theory approach, on one or the opposite in Associate in Nursing animal model. A participant value-added that although the anatomy within the mouse is totally different than the human, mutant letter of the alphabet mice area unit comparatively sensible models in this they recapitulate tau-dependent neurodegeneration. This has crystal rectifier several corporations to specialize in antibodies that block tau-dependent neurodegeneration in these mouse models.

This session includes Transgenic models, medicine and lesion models, Natural and semi natural models, Primate models, equine fish models, Animal models of human psychological feature aging, Development of latest animal models, genetic science of translational models, Protein-protein interactions, moral problems with animal models.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2019 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2019 USA | Dementia Conferences 2019 Europe | Dementia Conferences 2019 Asia | Brain Disorder Conferences

5th International Conference on Neuro-Oncology and Brain Tumor, February 27-28, 2019 Seoul, South Korea; 8th International Conference on Brain Injury and Neuroscience, March 14-15, 2019 Paris, France; CPD Accredited Annual Congress on Neurology & Neuroscience, March 14-15, 2019 Paris, France; 5th International Conference on Spine and Spinal Disorders, April 25-26, 2019 Rome, Italy; 9th International Conference on Addictive Disorders and Alcoholism, June 17-18, 2019 Brisbane, Australia; 32nd European Neurology Congress, July 22-24, 2019 London, UK; American Neuroscience and Neurosurgery Congress, June 21-22, 2019 Ottawa, Canada; World Congress on Advances in Brain Injury, October 21-22, 2019 Tokyo, Japan; 26th International Conference on Neurology: Neurochemistry, Neuropharmacology and Neurosciences, October 28-29, 2019 Abu Dhabi, UAE

Related Association:

USA and Canada:

Alternating Hemiplegia of Childhood Foundation; Alzheimer's Drug Discovery Foundation; Alzheimer's Association and Alzheimer's Foundation of America; American Association of Health and Disability; American Autoimmune Related Diseases Association; American Behcet's Disease Association and American Brain Coalition; American Brain Tumor Association; American Cancer Society; American Headache Society Committee for Headache Education; American Heart Association

European Union and UK:

Lowe Syndrome Association; The Alzheimer Society of Ireland; Alzheimer Society London; Alzheimer Society Middlesex; Alzheimer's & Dementia Help Germany; Alzheimer Europe; German Alzheimer Society; Federazione Alzheimer Italia

Asia-Pacific and Middle East:

Dementia Friends HK; Alzheimer's Disease Association of the Philippines; Dementia Society of the Philippines Dementia Caregiver Resources across India; Dementia Bangalore; Alzheimer's Disease – Aarogya; Japan - Dementia Friendly Communities; Grey zone - Coping with senility in Japan

Track 12: Recent Studies & Case Reports

Dementia may be a progressive, irreversible decline in noesis that, by definition, impacts on a patient pre-existing level of functioning. The clinical syndrome of dementedness has many etiologies of that Alzheimer’s sickness (AD) is that the most typical.

Drug development in AD is predicated on evolving pathophysiological theory. sickness modifying approaches embrace the targeting of amyloid process, aggregation of alphabetic character, endocrine signal, neuro-inflammation and neurochemical pathology, with efforts to date yielding abandoned hopes and current promise. reflective its dominance on the pathophysiological stage the amyloid cascade is central to several of the rising drug therapies.

  • Breakthrough in Dementia

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2019 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2019 USA | Dementia Conferences 2019 Europe | Dementia Conferences 2019 Asia | Brain Disorder Conferences

5th International Conference on Neuro-Oncology and Brain Tumor, February 27-28, 2019 Seoul, South Korea; 8th International Conference on Brain Injury and Neuroscience, March 14-15, 2019 Paris, France; CPD Accredited Annual Congress on Neurology & Neuroscience, March 14-15, 2019 Paris, France; 5th International Conference on Spine and Spinal Disorders, April 25-26, 2019 Rome, Italy; 9th International Conference on Addictive Disorders and Alcoholism, June 17-18, 2019 Brisbane, Australia; 32nd European Neurology Congress, July 22-24, 2019 London, UK; American Neuroscience and Neurosurgery Congress, June 21-22, 2019 Ottawa, Canada; World Congress on Advances in Brain Injury, October 21-22, 2019 Tokyo, Japan; 26th International Conference on Neurology: Neurochemistry, Neuropharmacology and Neurosciences, October 28-29, 2019 Abu Dhabi, UAE

Related Association:

USA and Canada:

Lewy Body Dementia Association; Jain Foundation and John Douglas French Alzheimer's Foundation; Intractable Childhood Epilepsy Alliance; Huntington's Disease Society of America; Michael J. Fox Foundation for Parkinson's Research; Children's Hemiplegia and Stroke Association; Christopher and Dana Reeve Foundation

European Union and UK:

Federazione Alzheimer Italia; Alzheimer's & Dementia Help; Giovanni B Frisoni; Association France Alzheimer; France - Dementia Friendly Communities; Alzheimer Society of Spain; Alzheimer Care in Spain

Asia-Pacific and Middle East:

Alzheimer And Related Dementia Society Nepal; Mental Illness Dementia and Family in China; Alzheimer Society of B.C.; Grey zone - Coping with senility in Japan; ARDSI Kolkata; Alzheimer's & Dementia Help; Dementia Caregiver Resources across India; Dementia Bangalore; Alzheimer's Disease – Aarogya

 

About Conference


Conference Series LLC LTD welcomes each one of the members from everyplace throughout the planet to travel to the insanity gathering that is command amid November 14-15, 2019 Paris, France. The principle subject of our meeting is "Advancements and breakthroughs within the fields of insanity analysis and Development" that covers intensive form of essentially important sessions. This meeting flow regarding enhancements within the field of insanity and about the new treatment techniques that square measure contrived by researchers to treat completely different maladies in less hard-to-please approach. This meeting goes concerning as a best stage for participants to search out concerning this pattern in insanity innovative work.

Dementia gathering can target the foremost recent and energizing developments in each facet of insanity think about that offers a noteworthy open door for agents over the world to fulfill, organize, and see new logical advancements. The 2 days gathering incorporates workshops, symposiums and exceptional keynote sessions semiconductor diode by notable and eminent speakers WHO exceed expectations within the field of insanity This Worldwide insanity Meeting likewise energizes the dynamic support of young understudies, forthcoming specialists and growing researchers as we have a tendency to square measure facilitating Poster Award Competition and Young analysis Forum at the gathering setting.

 

Target Group of onlookers:

  • Neurologists and Executives
  • Physicians
  • Neuroscientists
  • Specialists
  • researchers
  • Health mind experts
  • Professors
  • Industrial Specialists
  • Neurosurgeons
  • Psychiatrist
  • Nutritional Researchers
  • Lecturers and Understudies from the scholarly world in the investigation of Dementia
  • Students from the scholarly community in the examination of Neurology

Alzheimer Association & Societies around the Globe

  • Alzheimer's Australia
  • Albanian Alzheimer Society
  • Association de Lucha contra el Mal de Alzheimer
  • Foundation Alzheimer Aruba (FAA)
  • Alzheimer's Australia
  • Alzheimer Austria
  • Alzheimer Support Group
  • Alzheimer Society of Bangladesh
  • Barbados Alzheimer's Association Inc.
  • Alzheimer’s and Dementia Association of The Cayman Islands
  • Ligue National Alzheimer Liga
  • Alzheimer's Family Support Group
  • Association Bolivian de Alzheimery Otras Dementias
  • FEBRAZ - Federico Brasilia de Associaçãoes de Alzheimer
  • Corporation Alzheimer Chile
  • Alzheimer's disease Chinese
  • Alzheimer Association & Societies in Canada

 

 

Market Analysis

It is our pleasure to welcome you to the Dementia 2019 to be command in Paris, France from Nov 14-15, 2019.

Dementia is general term for memory misfortune and alternative intellectual capacities sufficiently real to intervene existence. This gathering can build info, offer help, facilitate learning and alter families and carers to go looking out relevant administrations for his or her idolized one and to create up the foremost ideal home condition to assist healing from this fascinating and decimating malady.

The global Alzheimer’s sickness (AD) market value $2.9 billion in 2016 is ready to achieve $14.8 Billon, rising at a Compound Annual rate of growth (CAGR) of seventeen.5%, across the 7 Million by 2026 consistent with world information, a recognized leader in providing business info and analytics Alzheimer's disease is that the commonest style of dementia. The proportions of these with totally different varieties of dementia are often dampened as follows:

Alzheimer's disease: sixty-two

Vascular dementia: Revolutionary Organization 17 November

Mixed dementia: 100%

Lewy-body dementia: four-dimensional

Fronto-temporal dementia: two

Parkinson's dementia: two

Other: 3%

Why Paris??

Paris is that the capital and most thickly settled town of France, with a district of one zero five sq. kilometers and official calculable population of 2,140,526 residents as of Jan 01st 2019. Since he seventeenth century, Paris is one of Europe’s major centers of finance, diplomacy, commerce, fashion, science and the arts. town of Paris is that the center and seat of presidency of the French region or Paris region, that has AN calculable official 2019 population of 12,213,364 or concerning eighteen percentage of the population of France. Paris is in northern central France, in a very north-bending arc of the stream Seine. Paris features a typical Western European oceanic climate. the protection of Paris is especially the responsibility of the Prefecture of Police of Paris, a subdivision of the Ministry of the inside of France. the foremost dear residential streets in Paris in 2018 by average value per area unit were Avenue Montaigne and Rue American state Furstenberg at 18,839 Euros per area unit.

Economy of town of Paris is predicated mostly on services and commerce of the 390,480 enterprises within the town, 80.6 % square measure engaged in commerce, transportation, and various services, 6.5 % in construction and 3.9 % in business. the bulk of Paris salaried workers fill 370,000 businesses services jobs, targeted within the north-western eighth sixteenth, seventeenth arrondissements. Paris was the third-busiest airline destination within the world, with 19.03 million guests behind port and London. Paris is a global capital of fashion since the nineteenth century significantly within the domain of high fashion, covering hand-made to order for personal shoppers.

Why to attend???

According to United Nations agency 47.5 million folks have dementedness and each year 7.7 million new cases square measure showing. By 2030 total cases of dementia is projected to be 75.6 million and virtually triple by 2050 to one hundred thirty-five.5 million. Alzheimer’s sickness contributes 60-70 you look after cases in dementia and second commonest condition of dementedness is tube-shaped structure dementia that contributes 2 hundredth of cases everywhere the globe. Total calculable price of dementedness is 818 billion U.S.A. $ in 2015.

A great chance to network together with your peers from academe and business. At the dementia conferences and from the eminent folk’s speech, you'll update your data concerning current of dementia analysis and receive name recognition at this 2-day event. World-renowned speakers, the foremost recent techniques, tactics, and the newest updates in dementia fields square measure hallmarks of this conference.

 

Conference Highlights:

Managing Dementia

Care Practice and Awareness

Alzheimer’s Disease Imaging

Causes and Prevention of Alzheimer’s

Alzheimer’s Disease Diagnosis and Symptoms

Alzheimer’s Disease Pathophysiology and Disease Mechanisms

Neurodegenerative Diseases

Vascular Dementia

Alzheimer’s Clinical Trials and Studies

Therapeutic Targets and Mechanisms for Treatment

Animal Models and Translational Medicine

Recent Studies & Case Reports

Alzheimer Association & Societies around the Globe:

Alzheimer's Australia

Albanian Alzheimer Society

Association de Lucha contra el Mal de Alzheimer

Foundation Alzheimer Aruba (FAA)

Alzheimer's Australia

Alzheimer Austria

Alzheimer Support Group

Alzheimer Society of Bangladesh

Barbados Alzheimer's Association Inc.

Alzheimer’s and Dementia Association of The Cayman Islands

Ligue National Alzheimer Liga

Alzheimer's Family Support Group

Association Bolivian de Alzheimer y Otras Dementias

FEBRAZ - Federico Brasilia de Associaçãoes de Alzheimer

Corporation Alzheimer Chile

Alzheimer's disease Chinese

Alzheimer Association & Societies in Canada

Products manufactured by the industries:

Three drugs are available to treat symptoms in people with Mild to moderate Alzheimer’s disease

Aricept™ produced by Pfizer Canada Inc.,

Exelon™ produced by Novartis Pharma Canada Inc.

Reminyl™ produced by Janssen Ortho Inc.

Two drugs for Moderate to advanced Alzheimer’s disease

Ebixa®

Aricept™

 

 

Past Conference Report

Dementia 2018

Dementia 2018 Report

The 12th International conference on Alzheimer’s Disease & Dementia, hosted by Conference series llc LTD was successfully held during October 29-31, 2018 in Valencia, Spain. The conference highlighted the theme “Investigating the Challenges and Excellence in Dementia Research”. The conference was successful in gathering eminent speakers from various reputed organizations and their paramount talks enlightened the gathering.

The pragmatic meet organized by CONFERENCE SERIES llc LTD received a generous response from the Editorial Board Members of CONFERENCE SERIES llc LTD Journals as well as expertise from academia, talented researchers and young student community. Researchers and students who attended from different parts of the world made the conference one of the most successful and productive events in 2018 from CONFERENCE SERIES llc LTD. The conference was marked by the presence of renowned Speakers, Young Researchers, Students and Business Delegates driving the Three-day event into the path of success with thought-provoking keynote and plenary presentations.

The highlights of the meeting where the keynote lectures from

  • Petr Zach, Charles University, Czech Republic
  • Magdalena Turek, Care Homes Zapiecek, Poland
  • T Y Chang, Geisel School of Medicine, USA
  • Catherine Chang, Geisel School of Medicine, USA
  • Mourad Tayebi, Western Sydney University, Australia

All the above-mentioned Honourable Guests and Keynote speakers gave their energetic and fruitful contributions and special thanks to our Moderator Dr. Gabriel González Pavón, Oncovision, Spain and Petr Zach, Charles University, Czech Republic for his remarkable contribution towards smooth functioning at Dementia 2018. The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

Alzheimer’s Disease: Diagnosis and Symptoms | Managing Dementia | Care Practice and Awareness | Alzheimer’s Disease Imaging | Causes and Prevention of Alzheimer’s | Alzheimer’s disease Pathophysiology and Disease Mechanisms | Amyloid Protein in Alzheimer’s and Dementia | Geriatrics Dementia and Cognitive Disorder | Therapeutic Targets and Mechanisms for Treatment | Animal Models and Translational Medicine | Vascular Dementia | Alzheimer’s disease and Dementia | Traumatic Brain Injury | Dementia with Lewy Bodies  | Alzheimer’s Clinical Trials and Studies

 To share your views and research, please click here to register for the Conference.

 CONFERENCE SERIES llc LTD would like to convey a warm gratitude to all OCM and Keynote Speakers of Dementia 2018 Conference.

Dementia 2018 Conference witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of Alzheimers disease and Dementia. The event enlightened various areas of Alzheimers disease and Dementia in different fields with plenary lectures from the speakers of various universities and organizations like

  • Xavier López-Gil, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Spain
  • Emily Gillett, The CareSide, Australia
  • W Kazana, Hirszfeld Institute of Immunology and Experimental Therapy-Polish Academy of Sciences, Poland
  • Shaymaa Abdulghaffar Abdulmalek, Alexandria University, Egypt
  • Muhammad Asif Rasheed, COMSATS University Islamabad, Pakistan
  • Etrat Hooshmandi, Shahid Beheshti University of Medical Sciences, Iran
  • Weonkuu Chung, Kyung Hee University Hospital, South Korea
  • Arooge Shafi, Gosford Private Hospital, Australia
  • Vesna Vuksanovic, University of Aberdeen, UK
  • Zagrebin V L, Volgograd State Medical University, Russia 
  • Soraya L Valles, University of Valencia, Spain

We are obliged to various delegate experts, institutes and other eminent personalities who actively took part in the discussion and meetings. We sincerely thank the Organizing Committee Members for their gracious presence and continuous support towards the success of Dementia 2018 Conference.

With the valuable feedback and generous response received from the participants of the event, CONFERENCE SERIES llc LTD would like to announce the commencement of the 13th International Conference on Alzheimer’s Disease & Dementia, November 14-15, 2019 in Paris, France.


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date November 14-15, 2019

Speaker Opportunity

Past Conference Report

Supported By

Journals of Alzheimers Disease and Parkinsonism Journal of Neurological Disorders Brain Disorders and Therapy

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner